Kessler Marla L 4

What Happened
Marla L. Kessler, a director of Ironwood Pharmaceuticals (IRWD), was granted 63,481 restricted shares on June 16, 2026. The grant is reported on a Form 4 as an award (transaction code A) at $0.00 per share (total reported value $0). This was a compensation grant to a non-employee director, not an open-market purchase or sale.

Key Details

• Transaction date: June 16, 2026; Form 4 filed June 17, 2026 (appears timely).
• Transaction type/code: Award / Grant (code A).
• Price reported: $0.00 per share; total reported value $0.
• Shares owned after transaction: Not specified in the provided filing details.
• Footnote: The restricted stock vests in full on the date immediately preceding the date of the company’s next annual meeting of stockholders (per the Second Amended and Restated Non-employee Director Compensation Policy, effective Jan 1, 2024).
• No indication of a 10b5-1 plan, cashless exercise, gift, or tax withholding in the supplied details.

Context
Restricted stock grants to directors are common as part of routine non-employee director compensation and do not require an upfront cash payment. Because these shares vest in the future, the grant does not necessarily reflect immediate trading intent; it’s a compensation event, not a sale. Retail investors should note the vesting timetable and monitor future Form 4s for any subsequent sales or withholding-related transactions at vesting.